Live Breaking News & Updates on அய்ய்ம்ஸ் பாட்னா

Stay updated with breaking news from அய்ய்ம்ஸ் பாட்னா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Govt's vaccine distribution policy not fair, has inequalities, alleges Rahul | India News


NEW DELHI: Congress leader Rahul Gandhi on Saturday alleged that the government s vaccine distribution has inequalities and is not fair.
I have been saying that the vaccines should be procured by the Centre and distributed by the states.
In the absence of a fair policy for vaccine distribution, the inequality in the Modi government s policy will give such results, he said citing a media report highlighting the inequalities in vaccine distribution.
The report claims that nine private hospitals got 50 per cent and six cities 80 per cent of Covishield and Covaxin stocks and alleged disparities in vaccine distribution.
Congress general secretary Priyanka Gandhi Vadra also hit out at the government, alleging shortage of beds during the second wave of coronavirus and asked why did it not upgrade health facilities and instead is carrying forward the central vista project. ....

Priyanka Gandhi Vadra , Parliamentary Committee On Health , Rahul Gandhi , Prime Minister , Parliamentary Committee , Central Vista , Ndia News , Ndia News Today , Oday News , Google News , Reaking News , பாராளுமன்றம் குழு ஆன் ஆரோக்கியம் , ராகுல் காந்தி , ப்ரைம் அமைச்சர் , பாராளுமன்றம் குழு , மைய விஸ்டா ,

No mortality among those re-infected with COVID-19 even after taking jab, suggests AIIMS study


FPJ
According to a recent study conducted by All India Institute Of Medical Sciences (AIIMS) in Delhi during April to May 2021, it was found that none of the vaccinated people had threat to life after getting re-infected with the COVID-19 virus. And that the disease was a rarity amongst those who were vaccinated.
AIIMS and CSIR-Institute of Genomics and Integrative Biology jointly analyzed 63 cases, mainly healthcare workers at the hospital itself.
Out of the 63 breakthrough infections, 36 patients received two doses, while 27 received at least one dose of the Covid-19 vaccine. Ten patients received Covishield, while 53 received Covaxin.
Of the 63 cases of vaccine breakthrough infections, including 36 who received full doses, there were no reports of mortality even though almost all cases presented with high-grade unremitting fever for 5-7 days, it added. ....

India Institute , All India Institute Of Medical Sciences , Integrative Biology , Chemiluminescent Immunoassay , இந்தியா நிறுவனம் , அனைத்தும் இந்தியா நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , ஒருங்கிணைந்த உயிரியல் ,